These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 25980368)

  • 1. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
    Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
    Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
    Zou M; Liu Z; Zhang XS; Wang Y
    Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer.
    Dowling P; Clarke C; Hennessy K; Torralbo-Lopez B; Ballot J; Crown J; Kiernan I; O'Byrne KJ; Kennedy MJ; Lynch V; Clynes M
    Int J Cancer; 2012 Aug; 131(4):911-23. PubMed ID: 21953030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A blood-based biomarker panel for stratifying current risk for colorectal cancer.
    Marshall KW; Mohr S; Khettabi FE; Nossova N; Chao S; Bao W; Ma J; Li XJ; Liew CC
    Int J Cancer; 2010 Mar; 126(5):1177-86. PubMed ID: 19795455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying joint biomarker panel from multiple level dataset by an optimization model.
    Zou M; Zhang PJ; Chen L; Tian YP; Wang Y
    Biomark Med; 2016 Jun; 10(6):567-75. PubMed ID: 27172589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating midkine in malignant and non-malignant colorectal diseases.
    Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
    Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals.
    Thorsen SB; Lundberg M; Villablanca A; Christensen SL; Belling KC; Nielsen BS; Knowles M; Gee N; Nielsen HJ; Brünner N; Christensen IJ; Fredriksson S; Stenvang J; Assarsson E
    J Transl Med; 2013 Oct; 11():253. PubMed ID: 24107468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple serological biomarkers for colorectal cancer detection.
    Chan CC; Fan CW; Kuo YB; Chen YH; Chang PY; Chen KT; Hung RP; Chan EC
    Int J Cancer; 2010 Apr; 126(7):1683-90. PubMed ID: 19795454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers.
    Ivancic MM; Megna BW; Sverchkov Y; Craven M; Reichelderfer M; Pickhardt PJ; Sussman MR; Kennedy GD
    J Surg Res; 2020 Feb; 246():160-169. PubMed ID: 31586890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer screening through a multi-analyte serum biomarker panel during health check-up examinations: Results from a 12-year experience.
    Wen YH; Chang PY; Hsu CM; Wang HY; Chiu CT; Lu JJ
    Clin Chim Acta; 2015 Oct; 450():273-6. PubMed ID: 26344337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis.
    Søreide K; Watson MM; Lea D; Nordgård O; Søreide JA; Hagland HR;
    J Transl Med; 2016 Jun; 14(1):192. PubMed ID: 27357108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hierarchical classifier based on human blood plasma fluorescence for non-invasive colorectal cancer screening.
    Soares F; Becker K; Anzanello MJ
    Artif Intell Med; 2017 Oct; 82():1-10. PubMed ID: 28939302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
    Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
    Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
    Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
    Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
    PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of composite circulating biomarker models for use in anticancer drug clinical development.
    Lancashire LJ; Roberts DL; Dive C; Renehan AG
    Int J Cancer; 2011 Apr; 128(8):1843-51. PubMed ID: 20549702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer.
    Sun F; Tan YA; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Ying HQ; Wang XZ
    J Clin Lab Anal; 2019 Jan; 33(1):e22635. PubMed ID: 30047185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.